Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Ion Exchange (India) Ltd

IONEXCHANG
NSE
396.40
0.23%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Ion Exchange (India) Ltd

IONEXCHANG
NSE
396.40
0.23%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
5,814Cr
Close
Close Price
396.40
Industry
Industry
Water Treatment
PE
Price To Earnings
25.84
PS
Price To Sales
2.01
Revenue
Revenue
2,886Cr
Rev Gr TTM
Revenue Growth TTM
7.52%
PAT Gr TTM
PAT Growth TTM
-16.23%
Peer Comparison
How does IONEXCHANG stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
IONEXCHANG
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
647479533554782568644691835583734734
Growth YoY
Revenue Growth YoY%
30.425.319.18.220.818.420.924.76.82.813.96.4
Expenses
ExpensesCr
541430473483690503576615749521665675
Operating Profit
Operating ProfitCr
1064960719264687586636859
OPM
OPM%
16.410.211.312.711.811.310.610.910.310.79.38.1
Other Income
Other IncomeCr
691191711159151815-4
Interest Expense
Interest ExpenseCr
224333434338
Depreciation
DepreciationCr
789101010111112121219
PBT
PBTCr
1024859679562687085666829
Tax
TaxCr
21141720231718202217188
PAT
PATCr
813342477245515063485021
Growth YoY
PAT Growth YoY%
-2.421.79.4-0.9-10.834.419.65.0-12.78.2-1.4-58.5
NPM
NPM%
12.57.08.08.59.37.97.97.27.68.36.82.8
EPS
EPS
6.928.13.64.06.13.84.34.15.34.14.21.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
8008711,0091,0461,1621,4801,4501,5771,9902,3482,7372,886
Growth
Revenue Growth%
0.98.815.83.711.127.3-2.08.826.218.016.65.4
Expenses
ExpensesCr
7548159399691,0561,3451,2471,3641,7352,0762,4432,610
Operating Profit
Operating ProfitCr
47567077107135202213255272294276
OPM
OPM%
5.86.46.97.49.29.114.013.512.811.610.79.6
Other Income
Other IncomeCr
4712213436334242455043
Interest Expense
Interest ExpenseCr
15151619191613109121317
Depreciation
DepreciationCr
121312132024282829364455
PBT
PBTCr
24355466102131195217259269285248
Tax
TaxCr
121825263637525664747765
PAT
PATCr
111729406694143162195195208182
Growth
PAT Growth%
138.748.170.638.265.442.952.212.820.60.26.6-12.5
NPM
NPM%
1.41.92.93.85.76.49.910.39.88.37.66.3
EPS
EPS
0.71.12.53.55.78.012.113.716.616.517.515.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
141414141414141414141414
Reserves
ReservesCr
1421561822162763775206708191,0041,1941,278
Current Liabilities
Current LiabilitiesCr
4684877458048529618999271,0511,2591,4681,410
Non Current Liabilities
Non Current LiabilitiesCr
485355585156394353170309406
Total Liabilities
Total LiabilitiesCr
6807169711,0651,1651,3821,4431,6251,9402,4492,9873,110
Current Assets
Current AssetsCr
5045277808629391,1291,1931,3471,6281,9512,1802,182
Non Current Assets
Non Current AssetsCr
176189191203227253250279312499807928
Total Assets
Total AssetsCr
6807169711,0651,1651,3821,4431,6251,9402,4492,9873,110

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
455017686127102197916313032
Investing Cash Flow
Investing Cash FlowCr
-17-25-72-166-70-18-29-92-40-160-165
Financing Cash Flow
Financing Cash FlowCr
-29-17-331-79-28-75-27-158128
Net Cash Flow
Net Cash FlowCr
-18101-49-235693-277-22-4
Free Cash Flow
Free Cash FlowCr
292113257967016742310-287
CFO To PAT
CFO To PAT%
397.3294.6611.3216.1192.1108.1137.556.532.266.515.4
CFO To EBITDA
CFO To EBITDA%
97.389.5253.4111.9118.875.697.442.924.647.810.9

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3784505707305848831,9162,4115,0057,4386,885
Price To Earnings
Price To Earnings
40.429.618.217.68.79.212.914.424.736.832.1
Price To Sales
Price To Sales
0.50.50.60.70.50.61.31.52.53.22.5
Price To Book
Price To Book
2.42.62.83.11.92.23.53.45.87.15.5
EV To EBITDA
EV To EBITDA
9.28.97.28.03.64.67.39.117.725.822.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
34.835.334.935.437.035.438.439.937.437.836.9
OPM
OPM%
5.86.46.97.49.29.114.013.512.811.610.7
NPM
NPM%
1.41.92.93.85.76.49.910.39.88.37.6
ROCE
ROCE%
16.719.823.722.631.629.234.830.830.024.019.5
ROE
ROE%
7.39.914.717.322.724.126.823.623.419.217.2
ROA
ROA%
1.72.43.03.75.76.89.99.910.18.07.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Overview** **Ion Exchange (India) Ltd.**, founded in **1964** as a subsidiary of Permutit, UK, is now a fully Indian-owned company headquartered in **Mumbai**. With over six decades of leadership, it is recognized as **Asia’s largest one-stop water and environmental solutions provider**, having executed over **100,000 installations** globally. The company offers end-to-end solutions across the entire **water cycle** — from pre-treatment and process water to wastewater, zero liquid discharge (ZLD), seawater desalination, and environmental management for industrial, municipal, residential, and rural applications. --- ### **Core Business Segments** Ion Exchange operates through three key verticals: 1. **Engineering (61% of FY25 Revenue)** - Delivers turnkey water and wastewater treatment plants via **EPC, LSTK, BOOT**, and **PPP** models. - Key technologies: **Seawater desalination**, **ZLD**, **membrane bioreactors (MBR)**, **waste-to-energy**, and **ultra-pure water systems**. - Serves high-impact sectors: **Power, Steel, Oil & Gas, Pharma, Electronics, Data Centers, Solar, and Municipal Infrastructure**. - Major recent project: Commissioned a **40 MLD desalination plant in North Africa**, with two more (60 MLD and 40 MLD) in execution. - **Order Book:** ₹2,711 crore (including UP SWSM and Sri Lanka projects). - **Order Inflows (Q1 FY26):** ₹470 crore. - **Bid Pipeline:** ₹9,011 crore, with a win ratio of **15–20%**. 2. **Chemicals (29% of FY25 Revenue)** - Core product: **INDION RESINS** — a full range of **cation** and **anion** exchange resins for water purification, pharmaceuticals (FDA-approved), nuclear-grade applications, and contaminant removal (e.g., fluoride, arsenic, PFAS, mercury). - Expanding into **green chemistry** and **sustainable processes**, including a **new greenfield resin plant** at **Roha, Maharashtra**, expected to be operational in Q2 FY25–26. - Strong **export presence** in North America, Europe (REACH-certified), and Africa. - Notable innovations: - **Indion GPS100** (PFAS removal), - **Indion PA600SPS** (pharma/biotech applications), - **Uranium removal resin** (successfully piloted in India). 3. **Consumer Products (10% of FY25 Revenue)** - Flagship brand: **ZeroB** — offering RO, UV, UF, and hydrogen-rich water purifiers, non-electric solutions, and institutional systems. - Key launches (2025): **Power Flow RO**, **UV Lite (low-cost online purifier)**, and **Indion® Quencher (MBR-based STP for institutions)**. - Sustainability innovation: **Auto Quencher** — robotic glass-bottling system to eliminate plastic waste in the hospitality sector. - Targeting **urban, institutional, and rural markets**, supported by **Jal Jeevan Mission** and CSR partnerships. --- ### **Global Presence & Strategy** - **Global Manufacturing & Sales Footprint**: - 7 manufacturing plants in **India** (Goa, Roha, Ankleshwar, etc.). - Facilities in **Portugal (Mapril acquisition)**, **UAE**, **Indonesia**, **Bangladesh**, and **Saudi Arabia**. - Subsidiaries in **USA, Oman, South Africa, Malaysia, Thailand**, and **Singapore**. - **International Revenue Drivers**: - **Ion Exchange LLC, USA**: 26% YoY revenue growth to ₹611 crores. - **Ion Exchange Arabia for Water (KSA)**: Secured major plant orders, including for **Ma’aden** pharma/mining complex. - **Ion Exchange Safic (Pty) Ltd, South Africa**: Profit up to ₹34.9 crores from ₹6.2 crores. --- ### **Strategic Partnerships & Technology Advancements** #### **MANN+HUMMEL Technology Licensing (Nov 2025)** - **Not a JV** — a **technology licensing and co-development partnership** for advanced membrane products. - Ion Exchange is now the **exclusive domestic partner** and global distributor (in operational markets) of MANN+HUMMEL’s water & membrane technologies. - **Key Products**: - **Hollow-Fiber Ultrafiltration (UF) Membranes** - **Membrane Bioreactors (MBR)** for wastewater - **Hot-Sanitizable RO Membranes** for biopharma - **Manufacturing**: At **Goa and Roha plants**, under a **co-branded Hydramem + MANN+HUMMEL** arrangement. - **Benefits**: - **Import substitution** and cost leadership in India. - Strengthened global competitiveness and faster deployment. - Positions Ion Exchange as a **strategic manufacturing hub** for MANN+HUMMEL. #### **Membrane Leadership** - Owns **HYDRAMEM-branded RO, UF (PES, PVDF), and nanofiltration membranes**. - **Goa membrane plant** at **100% capacity**, with expansion underway to meet surging demand. - Technology cost and efficiency improvements have driven **double-digit growth** and import substitution. --- ### **R&D and Innovation** - **2 R&D Centres** (notably in **Patancheru, Telangana**, DST-recognized). - **2 Application & Testing Centers** for pilot-scale validation. - Holds **50+ patents** and has commercialized **100+ products**. - Recent innovations: - **INDION TADOX** (licensed from TERI) — advanced photochemical oxidation for complex industrial waste. - **Low-pressure brine concentration** to reduce **ZLD costs**. - **Mercury removal resin**, **high-capacity defoamers**, and **chromatography resins**. --- ### **Growth Drivers & Market Strategy** - **Engineering Growth Focus**: - Targeting **technology-intensive** sectors: **Ultra-pure water (semiconductors, data centers)** and **biopharma**. - Expanding **standardized, skid-mounted systems** for faster project delivery. - Investing in **digital solutions**: - **IONSiTE Digital Solutions** (AI, digital twins, cloud-edge hybrid control). - **INDIONS Autochem** — remote monitoring and predictive maintenance. - **Capacity Expansion**: - **Roha Plant**: ₹200 crore capital work-in-progress; phased ramp-up over **3–4 years**. - Enhancements in **Goa, Hosur**, and integration of **Global Composites (Wada)** for manufacturing scalability. - **Geographic Expansion**: - India: Focus on **UP Jal Nigam**, **Har Ghar Jal**, and municipal PPPs. - Global: Strong pipeline in **Middle East, Africa, and Southeast Asia**. - Europe: **Portugal-based Mapril** used as a European **distribution and sales hub**. --- ### **Financials & Investment Highlights (as of Nov 2025)** - **Order Inflows (Q1 FY26)**: ₹470 crore. - **Total Bid Pipeline**: ₹9,011 crore (with visibility till March 2026). - **Engineering Order Book (Standalone)**: ₹2,711 crore (including UP & Sri Lanka). - **International Subsidiary Performance**: - **Oman**: Revenue ↑ to ₹253 crores, Profit after Tax ↑ to ₹19.1 crores. - **South Africa**: Turnover ↑ to ₹268 crores, PAT to ₹34.9 crores. - **USA**: Revenue ↑ 26% YoY. - **Cash Flow**: Strong customer advances (~₹10.2 crores from international subsidiaries). - **Investments & Assets**: Parent-level consolidated investments valued at **₹6,048 crore**, including stakes in key service and technology subsidiaries. --- ### **Sustainability & ESG Focus** - **Environmental Innovation**: - Waste-to-energy systems (bio-methanation for kitchen waste + sludge). - **Pavitra Ganga Project** (DST/DBT & EU-Horizon 2020) for urban wastewater treatment and reuse. - **Circular Economy**: - Recycles liquid/solid waste in resin manufacturing. - Promotes **plastic-free hospitality** via Auto Quencher system. - **Energy Efficiency**: - Focus on **High Recovery RO (HRR)**, **low-power desalination**, and **renewable energy integration**.